ArticleTherapeutics and clinical risk management2013

Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations.

Xiao-Ying Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.